Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)

NCT01651949 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2520

Enrollment

INDUSTRY

Sponsor class

Conditions

Genital Warts
Anal Cancer
Anal Intraepithelial Neoplasia

Interventions

BIOLOGICAL: 9vHPV Vaccine

Sponsor

Merck Sharp & Dohme LLC